investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

ALDEYRA THERAPEUTICS USD0.001
(01438T106)

Funds Reporting Holdings of ALDEYRA THERAPEUTICS USD0.001 according to 13F filings
Firm Name Shares Held / Principal Amount Market Value Option Report Period Effectiveness Date
683 Capital Management LLC 2,125,781 $12,755k Jun 30, 2019 Aug 14, 2019
Prosight Management LP 697,921 $4,188k Jun 30, 2019 Aug 14, 2019
Point72 Asset Management LP 325,000 $1,950k Jun 30, 2019 Aug 14, 2019
Gilder Gagnon HOWE & Co LLC 218,042 $1,308k Jun 30, 2019 Aug 13, 2019
Weiss Multi-Strategy Advisers LLC 200,000 $1,200k Jun 30, 2019 Aug 14, 2019
Woodstock Corporation 98,841 $593k Jun 30, 2019 Jul 3, 2019
Renaissance Technologies LLC 90,200 $541k Jun 30, 2019 Aug 12, 2019
PALO ALTO Investors LP 73,500 $441k Jun 30, 2019 Aug 14, 2019
Mesirow Financial Investment Management Inc 62,736 $373k Jun 30, 2019 Jul 12, 2019
Dafna Capital Management LLC 50,000 $300k Jun 30, 2019 Aug 14, 2019
Kepos Capital LP 33,301 $200k Jun 30, 2019 Aug 13, 2019
Algert Global LLC 29,840 $179k Jun 30, 2019 Aug 14, 2019
Falcon Point Capital LLC 24,701 $148k Jun 30, 2019 Jul 15, 2019
Ellington Management Group LLC 13,800 $83k Jun 30, 2019 Aug 14, 2019
Ellington Financial Management LLC 13,800 $83k Jun 30, 2019 Aug 14, 2019
Prelude Capital Management LLC 2,420 $15k Jun 30, 2019 Aug 14, 2019
Truvestments Capital LLC 990 $6k Jun 30, 2019 Jul 15, 2019

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.